LO
Lonza Group AG
LONN.SW · SIX
CHF 569.80 -2.10% (-CHF 12.20)
1M +0.11%
Market Cap CHF 40.5B
P/E Ratio 42.70x
Div. Yield 0.86%
ROE 10.78%
Bulios Fair Price
CHF 396.62
30.4% downside
Trenutna cena
CHF 569.8
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LONN.SW trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
22 /100
Expensive P/E 42.70x
PEG 0.87x
EV/EBITDA 33.58x
Growth
14 /100
Declining EPS growth 6.14%
Book val. growth 4.83%
Rev. growth 1.62%
Profitability
57 /100
Moderate Gross margin 35.35%
FCF margin 3.12%
Net margin 14.53%
Quality
42 /100
Average ROIC 7.27%
Asset turnover 0.34x
ROE 10.78%
Debt
73 /100
Low Debt/Equity 0.46x
Net debt/EBITDA 2.65x
Current ratio 2.24x
Stability
82 /100
Stable Beta 0.84x
Profitable years 6
Rev. volatility 5.44%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LONN.SW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Wolfgang Wienand
Employees
20,141
Headquarters
Basel